tradingkey.logo

Quince Marks Final Patient Visit in NEAT Phase 3 Study

ReutersDec 15, 2025 2:53 PM

- Quince Therapeutics Inc QNCX.O:

  • QUINCE THERAPEUTICS ANNOUNCES LAST PATIENT LAST VISIT IN PHASE 3 NEAT CLINICAL TRIAL IN PATIENTS WITH ATAXIA-TELANGIECTASIA

  • QUINCE THERAPEUTICS - EXPECTS TOPLINE RESULTS IN Q1 2026

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Related Articles

Tradingkey
KeyAI